MMP3 and myeloid sarcoma: Another study compared 90 MS cases and 20 controls in the Dutch GeneMSA cohort using the SomaLogic assay: the clearest difference between MS and controls was the downregulation of matrix metalloproteinase‐3 (MMP3) in MS cases.7